Medication for Acromegaly Reduces Expression of MUC16, MACC1 and GRHL2 in Pituitary Neuroendocrine Tumour Tissue

Acromegaly is a disease mainly caused by pituitary neuroendocrine tumor (PitNET) overproducing growth hormone. First-line medication for this condition is the use of somatostatin analogs (SSAs), that decrease tumor mass and induce antiproliferative effects on PitNET cells. Dopamine agonists (DAs) ca...

全面介紹

Na minha lista:
書目詳細資料
發表在:Front Oncol
Main Authors: Saksis, Rihards, Silamikelis, Ivars, Laksa, Pola, Megnis, Kaspars, Peculis, Raitis, Mandrika, Ilona, Rogoza, Olesja, Petrovska, Ramona, Balcere, Inga, Konrade, Ilze, Steina, Liva, Stukens, Janis, Breiksa, Austra, Nazarovs, Jurijs, Sokolovska, Jelizaveta, Pirags, Valdis, Klovins, Janis, Rovite, Vita
格式: Artigo
語言:Inglês
出版: Frontiers Media S.A. 2021
主題:
Oncology
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7928352/
https://ncbi.nlm.nih.gov/pubmed/33680922
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.593760
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍